282 related articles for article (PubMed ID: 26131423)
41. Cytogenetics, fluorescence in situ hybridization, and reverse transcriptase polymerase chain reaction are necessary to clarify the various mechanisms leading to an MLL-AF10 fusion in acute myelocytic leukemia with 10;11 rearrangement.
Klaus M; Schnittger S; Haferlach T; Dreyling M; Hiddemann W; Schoch C
Cancer Genet Cytogenet; 2003 Jul; 144(1):36-43. PubMed ID: 12810254
[TBL] [Abstract][Full Text] [Related]
42. Cryptic MLL-AF10 fusion caused by insertion of duplicated 5' part of MLL into 10p12 in acute leukemia: a case report.
Jarosova M; Takacova S; Holzerova M; Priwitzerova M; Divoka M; Lakoma I; Mihal V; Indrak K; Divoky V
Cancer Genet Cytogenet; 2005 Oct; 162(2):179-82. PubMed ID: 16213369
[TBL] [Abstract][Full Text] [Related]
43. [The value of detecting MLL gene rearrangement in children with acute monocytic leukemia].
Li R; Zhao D; Wang M; Zhang Z; Li L; Wang C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Aug; 36(8):777-780. PubMed ID: 31400126
[TBL] [Abstract][Full Text] [Related]
44. miR-101 suppresses the development of
Gonzales-Aloy E; Connerty P; Salik B; Liu B; Woo AJ; Haber M; Norris MD; Wang J; Wang JY
Haematologica; 2019 Jul; 104(7):e296-e299. PubMed ID: 30792205
[No Abstract] [Full Text] [Related]
45. Evidence-based RT-PCR methods for the detection of the 8 most common MLL aberrations in acute leukemias.
Burmeister T; Meyer C; Gröger D; Hofmann J; Marschalek R
Leuk Res; 2015 Feb; 39(2):242-7. PubMed ID: 25510485
[TBL] [Abstract][Full Text] [Related]
46. SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23).
Cerveira N; Correia C; Bizarro S; Pinto C; Lisboa S; Mariz JM; Marques M; Teixeira MR
Oncogene; 2006 Oct; 25(45):6147-52. PubMed ID: 16682951
[TBL] [Abstract][Full Text] [Related]
47. A novel MLL-SEPT2 fusion variant in therapy-related myelodysplastic syndrome.
Cerveira N; Santos J; Pinheiro M; Snijder S; van der Lelie H; Mellink CH; Teixeira MR
Cancer Genet Cytogenet; 2008 Aug; 185(1):62-4. PubMed ID: 18656699
[No Abstract] [Full Text] [Related]
48. Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair.
Ye J; Zha J; Shi Y; Li Y; Yuan D; Chen Q; Lin F; Fang Z; Yu Y; Dai Y; Xu B
Clin Epigenetics; 2019 Oct; 11(1):137. PubMed ID: 31590682
[TBL] [Abstract][Full Text] [Related]
49. Identification of CBL, a proto-oncogene at 11q23.3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia.
Fu JF; Hsu JJ; Tang TC; Shih LY
Genes Chromosomes Cancer; 2003 Jun; 37(2):214-9. PubMed ID: 12696071
[TBL] [Abstract][Full Text] [Related]
50. Validation of an interphase fluorescence in situ hybridization approach for the detection of MLL gene rearrangements and of the MLL/AF9 fusion in acute myeloid leukemia.
Cavazzini F; Bardi A; Tammiso E; Ciccone M; Russo-Rossi A; Divona D; Lo Coco F; Hernandez JM; Wlodarska I; Hagemeijer A; Castoldi G; Cuneo A
Haematologica; 2006 Mar; 91(3):381-5. PubMed ID: 16503549
[TBL] [Abstract][Full Text] [Related]
51. Cryptic t(6;11) KMT2A rearrangement in a pediatric acute myeloid leukemia patient detected by next-generation sequencing and dual-fusion FISH analysis.
Raghunandan S; Jain J; Saxe D; Pauly M; Aljudi AA; Ketterling RP; Carter AB; Raikar SS
Pediatr Blood Cancer; 2022 Mar; 69(3):e29428. PubMed ID: 34766724
[No Abstract] [Full Text] [Related]
52. High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis.
Kao HW; Liang DC; Kuo MC; Wu JH; Dunn P; Wang PN; Lin TL; Shih YS; Liang ST; Lin TH; Lai CY; Lin CH; Shih LY
Oncotarget; 2015 Oct; 6(32):33217-25. PubMed ID: 26375248
[TBL] [Abstract][Full Text] [Related]
53. Multiplex fusion gene testing in pediatric acute myeloid leukemia.
Iijima-Yamashita Y; Matsuo H; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Takahashi H; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
Pediatr Int; 2018 Jan; 60(1):47-51. PubMed ID: 29105243
[TBL] [Abstract][Full Text] [Related]
54. Use of MLL/GRAF fusion mRNA for measurement of minimal residual disease during chemotherapy in an infant with acute monoblastic leukemia (AML-M5).
Wilda M; Perez AV; Bruch J; Woessmann W; Metzler M; Fuchs U; Borkhardt A
Genes Chromosomes Cancer; 2005 Aug; 43(4):424-6. PubMed ID: 15852479
[No Abstract] [Full Text] [Related]
55. Integrated transcriptomic and epigenetic data analysis identifiesaberrant expression of genes in acute myeloid leukemia with MLL‑AF9 translocation.
Wang F; Li Z; Wang G; Tian X; Zhou J; Yu W; Fan Z; Dong L; Lu J; Xu J; Zhang W; Liang A
Mol Med Rep; 2020 Feb; 21(2):883-893. PubMed ID: 31789407
[TBL] [Abstract][Full Text] [Related]
56. Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement.
Park KU; Lee DS; Lee HS; Kim CJ; Cho HI
Am J Pathol; 2001 Dec; 159(6):2011-6. PubMed ID: 11733351
[TBL] [Abstract][Full Text] [Related]
57. Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemia.
Chen L; Sun Y; Wang J; Jiang H; Muntean AG
Oncotarget; 2016 May; 7(18):25208-23. PubMed ID: 27007052
[TBL] [Abstract][Full Text] [Related]
58. Panhandle PCR for cDNA: a rapid method for isolation of MLL fusion transcripts involving unknown partner genes.
Megonigal MD; Rappaport EF; Wilson RB; Jones DH; Whitlock JA; Ortega JA; Slater DJ; Nowell PC; Felix CA
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9597-602. PubMed ID: 10920186
[TBL] [Abstract][Full Text] [Related]
59. De novo acute myeloid leukemia associated with t(11;17)(q23;q25) and MLL-SEPT9 rearrangement in an elderly patient: a case study and review of the literature.
Lee SG; Park TS; Oh SH; Park JC; Yang YJ; Marschalek R; Meyer C; Cho EH; Shin SY
Acta Haematol; 2011; 126(4):195-8. PubMed ID: 21846973
[No Abstract] [Full Text] [Related]
60. Acquired persistently complete remission by decitabine-based treatment for acute myeloid leukemia with the
Wang F; Chen Y; Jiang N; Gong S; Cao T; Yuan J; Liu J; Xie L; Wu Y; Jia Y
Leuk Lymphoma; 2019 Dec; 60(13):3304-3307. PubMed ID: 31256701
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
